Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Nov
4
2024
EC Committee Issues Final Opinion on New Coating for Titanium Dioxide (Nano Form) Bergeson & Campbell, P.C.
Nov
4
2024
Financing Headwinds and the Future of Cell Cultivated Meat Womble Bond Dickinson (US) LLP
Nov
4
2024
China Notifies Requirements for Safety Evaluation Materials for “Three New Foods” Keller and Heckman LLP
Nov
4
2024
Quantum Computing’s Transcendence: Impacts on Industry Foley & Lardner LLP
Nov
4
2024
Medicare Overpayments: CMS Issues Final Regulations Implementing Changes to 60-day Refund Rule Foley & Lardner LLP
Nov
4
2024
TGI Friday’s Files for Chapter 11 Bankruptcy Protection Stark & Stark
Nov
3
2024
California Law Requires Heavy Metals Testing and Disclosure for Baby Foods Keller and Heckman LLP
Nov
2
2024
A Conversation with Deputy Commissioner Jim Jones [Podcast] Bergeson & Campbell, P.C.
Nov
1
2024
Slicing Through Insufficient Evidence of Infringement, Willfulness, and Damages Sheppard, Mullin, Richter & Hampton LLP
Nov
1
2024
CODEX ALIMENTARIUS: Main Outcomes of 44th Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU44) Keller and Heckman LLP
Nov
1
2024
Campaign Promises to Address Rising Prices at the Grocery Store Signal Stronger Price Gouging Investigations, Enforcement Actions, and Prohibitions to Come Sheppard, Mullin, Richter & Hampton LLP
Nov
1
2024
Connecticut State Court Finds Defunct Pharmacy Liable for $39.2 Million in Damages and Penalties ArentFox Schiff LLP
Nov
1
2024
What Cosmetic Companies Need to Know About the CPSC Foley & Lardner LLP
Nov
1
2024
Expected Further Extension of COVID-19 Telemedicine Flexibilities for Prescriptions of Controlled Medications Norris McLaughlin P.A.
Nov
1
2024
Should The Secretary Of State Accept Filings By Cannabis-Related Business Entities? Allen Matkins Leck Gamble Mallory & Natsis LLP
Oct
31
2024
FDA Finalizes New Enforcement Policy for Animal Feed Ingredients; AAFCO Proposes Expert Panel Ingredient Review Process at K-State Olathe Keller and Heckman LLP
Oct
31
2024
Not My Problem: Connecticut Federal Court Rules Hemp Lawsuit Is a State Issue Bradley Arant Boult Cummings LLP
Oct
31
2024
Court of Appeal: "We Regret to Inform That Cannabis Is Illegal in California Because Federal Law Says So" Allen Matkins Leck Gamble Mallory & Natsis LLP
Oct
30
2024
This Week in 340B: October 22 – 28, 2024 McDermott Will & Emery
Oct
30
2024
Stakeholders Raise 340B Concerns in Medicaid Drug Rebate Program Final Rule; CMS, With Hands Tied, Shrugs Mintz
Oct
30
2024
FDA Issues Pair of Warning Letters for Violation of FSVP Requirements Keller and Heckman LLP
Oct
30
2024
Arizona Court Says Preschool Isn’t School, Showing That Sometimes There Isn’t a “Right” Decision Bradley Arant Boult Cummings LLP
Oct
29
2024
OSHA Enforcement Memo for Animal Slaughtering and Meat Processing Industries Portends In-Depth, Lengthy Investigations Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
29
2024
Organic Food Group Asks 9th Circuit to Upend GMO Label Rule Keller and Heckman LLP
Oct
28
2024
Exemptions from the Drug Supply Chain Security Act Enhanced Drug Distribution Security Requirements Epstein Becker & Green, P.C.
Oct
28
2024
From Opioids to Opt-Outs: Nonconsensual Third-Party Releases and the Aftermath of Purdue Proskauer Rose LLP
Oct
28
2024
Update: Federal and State Agencies Release Telehealth-Related Updates Bradley Arant Boult Cummings LLP
Oct
28
2024
Michigan Court Prohibits Sale of Illegal Marijuana in a Ruling Straight Out of “Duh” Magazine Bradley Arant Boult Cummings LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins